Narrow DCIS Margins May Not Always Warrant Reexcision - Summary - MDSpire

Narrow DCIS Margins May Not Always Warrant Reexcision

  • By

  • Andrea Surnit

  • July 20, 2026

  • 6 min

Share

Objective:

To evaluate the association between margin width and ipsilateral breast tumor recurrence (IBTR) in postmenopausal patients with hormone receptor-positive ductal carcinoma in situ (DCIS).

Approach:
  • Study Design: Ancillary analysis of prospectively collected margin data from the phase 3 NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-35 trial.
  • Patient Population: 3,104 postmenopausal patients with hormone receptor-positive DCIS and tumor-free margins enrolled from January 2003 to June 2006.
  • Margin Analysis: Evaluated IBTR using protocol-defined margin groups of <1 mm vs ≥1 mm and guideline-based groups of <2 mm vs ≥2 mm.
  • Statistical Methods: Calculated 10-year cumulative incidence while accounting for competing risks and adjusted for age, endocrine therapy assignment, and tumor size.
Key Findings:
  • 10-year cumulative incidence of IBTR was 5.6% for margins <1 mm and 4.0% for margins ≥1 mm (unadjusted difference significant).
  • In the 2-mm analysis, IBTR was 5.3% for margins <2 mm and 3.8% for margins ≥2 mm (unadjusted difference significant).
  • After adjustment, margin width was not statistically significantly associated with IBTR at either threshold.
  • Tumor size was associated with recurrence; tumors ≥1 cm had approximately twice the adjusted hazard of IBTR compared to smaller tumors.
  • 65% of patients completed 5 years of endocrine therapy, with no difference in adherence by margin group.
Interpretation:

Limitations:
  • Margin width was not randomized and no intervention based on margin width was included.
  • Margin status assessed by local pathologists without real-time central review.
  • Excluded patients included those with positive margins and missing pathology forms.
  • Tumor size was estimated in a significant portion of patients.
  • Analysis did not address premenopausal patients or hormone receptor-negative DCIS.
Conclusion:

Sources:

Original Source(s)

Related Content